ESC Council of Cardio-Oncology

Who We Are

In the coming years there will probably be a cardio-oncology ‘epidemic’ due to either the growing population of cancer survivors, the increasing number of patients aged over 65 who need chronic cancer therapy and the high frequency of cancer therapy induced CVDs in these populations.

The main goal of cardio-oncology is to reduce the burden of CVDs in oncologic patients allowing them to receive the best antitumour therapy (chemotherapy, targeted molecular therapies, hormone therapy, immunotherapy or radiotherapy) with the lowest rate of side effects and treatment interruptions.

Consequently, the ESC created the Council of Cardio-Oncology in August 2018 as a multidisciplinary constituent body which encourages the prevention, early diagnosis and management of cancer therapy-related cardiovascular diseases.

Today, the council brings together over 2,000 members worldwide and a team of volunteers part of the Council of Cardio-Oncology Board.

ESC Councils' Internal Governance Procedures

Our vision

Our aims are to bring together European and non-European specialists in the field, and specialists from oncology, haematology, radiotherapy and related disciplines to improve the prevention, diagnosis, treatment and management of cancer therapy-related cardiovascular diseases and enhance the  standard of care for cardio-oncology patients.

We work in line with the ESC Strategic Pillars: Advocacy, Congresses, Research, Membership and Education.

What we do

The Council is active in a number of areas, including :

• Organising 'ESC Cardio-Oncology 2025' from 20-21 June in Florence (Italy)
• Producing cardio-oncology educational content
• Writing position papers and consensus statements on aspects of cardio-oncology
• Developing the programme for the cardio-oncology sessions for ESC Congress and contributing to other ESC subspecialty congresses
• Collaborating with the ESC Advocacy Division to help shape the EU's beating cancer plan
• Producing a regular newsletter for members